Reduction of corticosteroid use in outpatient treatment of exacerbated COPD - Study protocol for a randomized, double-blind, non-inferiority study, (The RECUT-trial)

BACKGROUND: Chronic obstructive pulmonary disease (COPD) is a major public health issue affecting approximately 4% to 7% of the Swiss population. According to current inpatient guidelines, systemic corticosteroids are important in the treatment of acute COPD exacerbations and should be given for 5 t...

Descripción completa

Detalles Bibliográficos
Autores principales: Urwyler, Pascal, Boesing, Maria, Abig, Kristin, Cattaneo, Marco, Dieterle, Thomas, Zeller, Andreas, Bachler, Herbert, Markun, Stefan, Senn, Oliver, Merlo, Christoph, Essig, Stefan, Ullmer, Elke, Rutishauser, Jonas, Schuurmans, Macé M, Leuppi, Joerg Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6916452/
https://www.ncbi.nlm.nih.gov/pubmed/31842993
http://dx.doi.org/10.1186/s13063-019-3856-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6916452/
https://www.ncbi.nlm.nih.gov/pubmed/31842993
http://dx.doi.org/10.1186/s13063-019-3856-8

Ejemplares similares